Astrana Health Stock (NASDAQ:ASTH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$54.53

52W Range

$28.87 - $63.20

50D Avg

$54.82

200D Avg

$44.84

Market Cap

$2.67B

Avg Vol (3M)

$252.03K

Beta

1.22

Div Yield

-

ASTH Company Profile


Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

1,800

IPO Date

Mar 11, 2009

Website

ASTH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 24
Health Care Capitation Revenue$442.57M
Health Care, Other$18.41M
Health Care, Patient Service$19.96M
Management Service$1.60M
Product and Service, Other$3.72M

Fiscal year ends in Dec 23 | Currency in USD

ASTH Financial Summary


Dec 23Dec 22Dec 21
Revenue$1.39B$1.14B$773.91M
Operating Income$84.61M$104.27M$98.18M
Net Income$60.72M$45.17M$68.92M
EBITDA$128.27M$133.35M$109.21M
Basic EPS$1.30$1.00$1.57
Diluted EPS$1.29$0.99$1.52

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 07, 24 | 9:02 PM
Q1 24May 07, 24 | 12:00 AM
Q4 23Feb 27, 24 | 11:30 PM